WIB22: Leading NK cell researcher reflects on roots in Iran, the UK and Texas
This profile is part of Endpoints News’ 2022 special report about Women in Biopharma R&D. You can read the full report here.
In a small but widely-cited 11-person study published in NEJM in 2020, seven patients saw signs of their cancer completely go away after getting a new therapy made from natural killer cells. The study was one of the earliest to provide clinical proof that the experimental treatment method had promise.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
